CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapyJohannes Sam, Pablo Umaña, Thomas Höfer et al.|Blood|2024Cited by 40
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndromeGail J. Roboz, Daniel J. DeAngelo, Eric S. Winer et al.|Leukemia & lymphoma/Leukemia and lymphoma|2021Cited by 35